SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
FBXO40 | F-box protein 40 | Plasma proteins
| | | | | Group enriched |
HEPN1 | Hepatocellular carcinoma, down-regulated 1 | | | | | | Group enriched |
HRC | Histidine rich calcium binding protein | Predicted secreted proteins
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
C10orf71 | Chromosome 10 open reading frame 71 | | | | | | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
KLK1 | Kallikrein 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
PROZ | Protein Z, vitamin K-dependent plasma glycoprotein | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TMEM213 | Transmembrane protein 213 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACTN2 | Actinin, alpha 2 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
CUBN | Cubilin (intrinsic factor-cobalamin receptor) | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FSD2 | Fibronectin type III and SPRY domain containing 2 | | | | | | Group enriched |
HEMGN | Hemogen | | | | | | Group enriched |
NCCRP1 | Non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) | | | | | | Group enriched |
PRAC1 | Prostate cancer susceptibility candidate 1 | | | | | | Group enriched |
UGT2A2 | UDP glucuronosyltransferase 2 family, polypeptide A2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
DEFB132 | Defensin, beta 132 | Predicted secreted proteins
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
CCDC37 | Coiled-coil domain containing 37 | | | | | | Group enriched |
MBD3L1 | Methyl-CpG binding domain protein 3-like 1 | | | | | | Group enriched |
OBP2A | Odorant binding protein 2A | Predicted secreted proteins
| | | | | Group enriched |
TTN | Titin | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
FAM19A3 | Family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 | Predicted secreted proteins
| | | | | Group enriched |
HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
IL1F10 | Interleukin 1 family, member 10 (theta) | | | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MYPN | Myopalladin | Disease related genes
| | | | | Group enriched |
TEX15 | Testis expressed 15 | | | | | | Group enriched |
TMIGD1 | Transmembrane and immunoglobulin domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
UPB1 | Ureidopropionase, beta | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
C19orf69 | Chromosome 19 open reading frame 69 | | | | | | Group enriched |
CALML5 | Calmodulin-like 5 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
KLHL38 | Kelch-like family member 38 | | | | | | Group enriched |
LSP1 | Lymphocyte-specific protein 1; Uncharacterized protein | | | | | | Group enriched |
MYO18B | Myosin XVIIIB | | | | | | Group enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes
| | | | | Group enriched |
REG3A | Regenerating islet-derived 3 alpha | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SLURP1 | Secreted LY6/PLAUR domain containing 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
AL109927.1 | HCG2032222; PRO2047; Uncharacterized protein | | | | | | Group enriched |
BTNL3 | Butyrophilin-like 3 | Predicted membrane proteins
| | | | | Group enriched |
CAPNS2 | Calpain, small subunit 2 | | | | | | Group enriched |
CYP4F31P | Cytochrome P450, family 4, subfamily F, polypeptide 31, pseudogene | | | | | | Group enriched |
KCNJ4 | Potassium inwardly-rectifying channel, subfamily J, member 4 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
LRRC38 | Leucine rich repeat containing 38 | Predicted membrane proteins
| | | | | Group enriched |